BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Actavis to Close Research Unit in Malta


3/11/2013 8:35:34 AM

Pharmaceutical company Actavis has decided to close down the research and development department in Bulebel, where 60 employees work. While insisting that no jobs had been terminated yet, Actavis Malta’s managing director, Sergio Vella, explained that, following the acquisition by US giant Watson, the company ended up with many R&D units worldwide, creating duplication of work. Last December, the company closed down an R&D unit in the US and another one in Greece was closed last week. The employees at the Bulebel unit, with an average age of 38, received an e-mail at 7am yesterday, calling them to an urgent meeting at 11am. Some of those who were on long leave or maternity leave were also asked to attend. The meeting was addressed by Watson’s vice president R&D and by the vice president human resources, who came to Malta specifically to address the employees. The workers were given a presentation of the R&D situation and were informed of the company’s decision to close down Malta’s R&D arm by the end of the year. They were told in advance so that those who preferred to could seek employment elsewhere. Mr Vella said the decision was part of the company’s global restructuring process. The Finance Ministry confirmed the company’s decision, noting it would not affect the rest of the 1,000-strong workforce. Later in the day, Malta Enterprise had an urgent meeting with managers on the decision of the international management. The two sides reached an agreement for the talks to continue, the ministry said. It said the company’s local management would be making proposals that would be discussed with Malta Enterprise, with the aim of finding a solution that would safeguard the people affected.

Read at News Release

Actavis
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES